Inside Innovation

Evergreen Bioscience Innovation chose a tentative location for its new headquarters in Spokane’s University District. The organization notes that this may change before plans are

Nonprofit organization Trust for Public Land ranked Seattle’s public park system as the eighth-best in the country. The study ranked the park systems of America’s

Washington’s life sciences continue to grow, with activity spurred by mergers and acquisitions. In fact, three of this year’s 10 largest biotech acquisitions nationwide have

Seattle-based biotech company Kineta will receive $5 million from Merck after achieving a milestone in development efforts. Although Kineta is centered around oncology and cancer

A professor at the University of Washington School of Medicine teamed up with Seattle biotech company RareCyte, Inc. to create a blood test that measures

Seattle-based biotech company AltPep has raised $52.9 million in a Series B round. The funding follows previous investments of $44.4 million in 2022 and $23

Seattle-based Fred Hutchinson Cancer Center will extend its education offerings to eastern Washington this summer during a three-week STEM program for teachers. The announcement follows

Vulcan Inc., a Seattle-based development and real estate company, will move forward with the construction of a lab research facility after receiving approval from a

Seattle-based biotech company Seagen appears to have found success with a drug in its phase II trials of early-stage classical Hodgkin lymphoma, with 93% of

Life Science Washington Institute announced two new grant programs at its annual East West Summit. The grants will be used to fund life sciences startups

OtoNexus Medical Technologies, a Bellevue-based company, is among Puget Sound Business Journal’s “Washington’s 100 best workplaces.” OtoNexus is one of only 25 small companies –